acheter metformin online proscar sur le comptoir acyclovir vente zithromax sans ordonnance acheter actos en ligne spironolactone sur le comptoir
  • nonspecific urethritis protocol bactrim buy cheap viagra online uk commander du viagra au canada priligy usa celebrex and dosage kamagramg oral jelly usa cheapest viagra prices viagra for sale avodart and pregnancy
  • viagra receptfri vendesi viagra senza ricetta viagra mit rezept tadalafil générique viagra på nätet levitra similar viagra acquisto viagra paypal
  • bactrim given during rd trimester cialis online usa cialis buy online avodart full prescribing information viagra instructions how to get viagra nolvadex and burn fat mestinon venta libre donepezil comprar en línea
    viagra generico senza ricetta cialis lilly precio viagra zoeken
    cialis berlin 
    günstig viagra kaufen 
    viagra rezeptfrei in österreich 

    Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

    Mon, Jun 20, 2011

    Oral Cancer News

    Source: The Lancet



    Australia introduced a human papillomavirus (HPV) vaccination programme with the quadrivalent HPV vaccine for all women aged 12—26 years between 2007 and 2009. We analysed trends in cervical abnormalities in women in Victoria, Australia, before and after introduction of the vaccination program.


    With data from the Victorian Cervical Cytology Registry between 2003 and 2009, we compared the incidence of histopathologically defined high-grade cervical abnormalities (HGAs, lesions coded as cervical intraepithelial neoplasia of grade 2 or worse or adenocarcinoma in situ; primary outcome) and low-grade cytological abnormalities (LGAs) in five age groups before (Jan 1, 2003, to March 31, 2007) and after (April 1, 2007, to Dec 31, 2009) the vaccination programme began. Binary comparisons between the two periods were done with Fisher’s exact test. Poisson piecewise regression analysis was used to compare incident rate trends.


    After the introduction of the vaccination programme, we recorded a decrease in the incidence of HGAs by 0·38% (95% CI 0·61—0·16) in girls younger than 18 years. This decrease was progressive and significantly different to the linear trend in incidence before introduction of the vaccination (incident rate ratio 1·14, 1·00—1·30, p=0·05). No similar temporal decline was recorded for LGAs or in older age groups.


    This is the first report of a decrease in incidence of HGAs within 3 years after the implementation of a population-wide HPV vaccination programme. Linkage between vaccination and screening registers is needed to confirm that this ecological observation is attributable to vaccination and to monitor participation in screening among vaccinated women.



    Print Friendly
    Be Sociable, Share!
    , , , ,

    Leave a Reply

    You must be logged in to post a comment.